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Negev, Beer-Sheva, IsraelBACKGROUND & AIMS: The diagnostic criteria for fecal incontinence (FI) were made more restrictive in the Rome IV
revision. We aimed to determine the characteristics of FI patients defined by the Rome IV
criteria, assess how FI frequency and amount affect quality of life, identify risk factors, and
compare prevalence values among countries.METHODS: We performed an internet-based survey of 5931 subjects in the United States, Canada, and the
United Kingdom, from September to December 2015. Subjects were stratified by country, sex,
and age. Responders answered questions about diagnosis, health care use, and risk factors. We
performed multivariate linear regression analysis to identify risk factors for FI.RESULTS: FI was reported by 957 subjects (16.1%) but only 196 (3.3%) fulfilled the Rome IV criteria.
Frequency of FI was less than twice a month for 672/957 subjects (70.2%) and duration was
less than 6 months for 285/957 subjects (29.8%). Quality of life was significantly impaired in all
subjects with FI compared to subjects with fecal continence. The strongest risk factors for FI
were diarrhea, urgency to defecate, and abdominal pain. FI was more prevalent in the United
States than in the United Kingdom. Between-country differences were due to less diarrhea and
urgency in the United Kingdom.CONCLUSIONS: Rome IV FI prevalence is lower than previous estimates because the new criteria exclude many
individuals with less frequent or short duration FI. These excluded patients have impaired
quality of life. It might be appropriate to make a diagnosis of FI for all patients with FI ‡2 times
in 3 months and to provide additional information on frequency, duration, and amount of stool
lost to assist clinicians in treatment selection.Keywords: Quality of Life; Risk Factors; Diarrhea; Urgency; Accidental Bowel Leakage.Fecal incontinence (FI) is the unintended loss ofsolid or liquid stool.1,2 It occurs in 7%–15% of
individuals, with variability caused by the diagnostic
criteria used, the age group in which it is studied, and
any chronic illnesses present.3 FI has a major impact on
health-related quality of life4 causing social isolation and
increasing the likelihood among older adults of referral
to a nursing home.5 Changes to the diagnostic criteria
for FI are important because it is prevalent and has a
large effect on quality of life.The Rome Foundation recommended diagnostic
criteria for FI in 2006 (Rome III criteria)6 and revised
them in 2016 (Rome IV criteria).7 In both cases, FI was
defined as multiple episodes of solid or liquid stool
passed into clothes, and accidental loss of flatus was
ignored.6,7 Rome III and Rome IV identify patients with
FI based on the frequency of accidental loss of solid or
liquid stool and the duration of the disorder.
What You Need to Know
Background
We aimed to determine the characteristics of FI pa-
tients defined by the Rome IV criteria, assess how FI
frequency and amount affect quality of life, identify
risk factors, and compare prevalence values among
countries.
Findings
An internet survey of 6300 United States, Canadian,
and British subjects found fecal incontinence in
16.1%, but only 3.3% met Rome IV criteria. Excluded
subjects had impaired quality of life.
Implications for patient care
It may be appropriate to diagnose FI in all patients
with 2 or more incidences in 3 months, and to pro-For Rome III at least 1 FI event per month is 
required6 but for Rome IV at least twice a month is 
needed. An unintended consequence of requiring a 
higher frequency of FI for diagnosis in Rome IV is that 
many people with occasional FI are no longer diag-
nosed. It is not clear how these individuals should be 
managed by clinicians, and that is 1 of the reasons for 
comparing the quality of life in FI defined by different 
criteria.
The aims of this study were (1) to determine the 
prevalence of FI by all diagnostic criteria, (2) assess 
quality of life in each subgroup, (3) identify risk factors 
for FI, and (4) compare prevalence rates in different 
countries. These countries were the United States, 
English-speaking parts of Canada, and the United 
Kingdom. These comparisons enabled us to determine 
whether FI is stable across countries and whether risk 
factors for FI differ among countries.vide additional information on frequency, duration,
and amount of stool lost to assist clinicians in
treatment selection.Methods
This survey methodology and content has been pre-
viously described.8 A total of 2100 subjects were
recruited from Internet registries in the United States,
Canada, and the United Kingdom by Qualtrics (Provo,
UT). These individuals volunteered to participate in
community surveys on a variety of topics, such as market
research or politics. In exchange, participants received
credits toward the purchase of products. Subjects
remained anonymous to the investigators. In this survey,
Qualtrics was given quotas of demographic characteris-
tics to match including 50% males; 40% aged 18–39,
40% aged 40–64, and 20% aged 65 or older; and no
more than 30% with a college degree. For the United
States, participants should include 20% African Amer-
ican and 20% Hispanic. The study invitation and consent
form described the survey as a health survey with no
mention of gastrointestinal disorders. Subjects were
directed to a Web site where they completed question-
naires. Data analysis occurred at the University of North
Carolina.
Several methods were used to ensure data quality: 3
questions from early in the survey were repeated a sec-
ond time, and a difference of greater than 2 response
steps (out of 8) on any of these 3 questions caused the
subject to be rejected. We also measured how much time
subjects took to complete the survey and eliminated those
who were more than 3 times faster than the median for
early participants. Also excluded were those who failed
either of 2 attention-check questions. Excluded re-
spondents were 5.9%, leaving 5931 for analysis.
Any Internet survey must show that the data are
representative. We previously showed that this Internet
sample is unbiased by sex, age, race, and education after
the Internet provider fills the demographic quotas below.
It compares favorably with random telephone surveys or
door-to-door or mailed surveys, which are limited by thereluctance of many individuals to respond to unsolicited
telephone calls or mail.
Survey Questions
The primary questions came from the Rome IV Diag-
nostic Questionnaire for Adults (86 questions).9 FI is diag-
nosed by 2 questions: (1) In the last 3months, howoften did
you have accidental leakage of stool (fecal material)? The
minimum frequency for diagnosis was 1 day for Rome III
and 2 days for Rome IV. (2) Has it been 6 months or longer
since you started having accidental leakage of stool? Rome
IV diagnosis required a “yes” response.
The average amount of stool lost was asked. Although
not in the diagnostic criteria for FI, “amount” is included
because it is often used to select research participants for
studies. Possible answers were a small amount (only
enough to stain underwear), moderate amount (more
than staining but less than a full bowel movement), or
large amount (a full bowel movement). The moderate
and large volume choices were combined because only
3.6% reported losing a full bowel movement.
Variations in the criteria used to diagnose FI may
exclude some subjects who have infrequent or milder
forms of FI, and it is important to know if this subgroup
has impaired health-related quality of life. The validated
Short Form-8 scale includes subscales for a physical
component and a mental component of quality of life.10
Additional psychological symptom scales included ques-
tions about howmuch bowel symptoms concern the subject,
how embarrassing those symptoms were, and whether psy-
chological stress made the symptoms worse. The Patient
Health Questionnaire-1211 was used as a measure of soma-
tization; it was included because the Brief Symptom In-
ventory has been shown to predict FI occurrence.12
Additional questions on gastrointestinal health his-
tory, use of medications, and health care use were based 
on previous surveys. An international diet questionnaire 
was constructed by identifying the 10 most common 
foods eaten globally and asking subjects to report the 
number of days per week they consumed each food type.Data Analysis
Sex, age, and education were controlled by the Internet
provider. Student t tests or chi square tests were used to
compare prevalence rates within and between countries.
Variability was shown by 95% confidence intervals.
Table 1 shows the impact of changes in the diagnostic
criteria on the prevalence of FI followed by the propor-
tion meeting Rome III and Rome IV criteria.
A key aim of the study was to assess the impact of
limitations on diagnostic criteria to quality of life. T-tests
were used to compare the quality of life in the “never had
FI” subgroup with the quality of life in other subgroups
with FI.
Independent risk factors were identified by binary
logistic regression. Three regression models were used
to identify independent predictors of any FI, Rome III FI,
and Rome IV FI.
The last aim was to compare FI prevalence among
countries and identify variables that could explain dif-
ferences in FI prevalence. Logistic regression was used to
identify independent risk factors. Variables were
considered to be significant predictors if their inclusion
as a covariate eliminated differences among countries in
the prevalence of any FI in the last 3 months.
The study was reviewed by the University of North
Carolina Institutional Review Board and determined not
to require institutional review because all data were
anonymous. There were no risks for participants. All
authors had access to the study data and reviewed and
approved the final manuscript.
Results
The samples were balanced (less than 2% difference
between countries) in sex and age because of quotaTable 1. Prevalence of FI by Countrya
United States Cana












CI, confidence interval; FI, fecal incontinence.
aIn each cell: percent of country sample, number of subjects.
bBolded numbers are significantly different between the United States and the Usampling. On education, US subjects were less likely to
have post-graduate or professional training than Cana-
dian or UK subjects (P < .05).
Race accounted for the greatest differences between
countries. In the United States, quota-controlled sam-
pling led to 20.2% for blacks, which was significantly
higher than Canada and the United Kingdom (P < .01).
Canada had significantly more Asians than the United
States or United Kingdom (P < .01). FI was not signifi-
cantly related to race within any country.Prevalence Rates for Fecal Incontinence by
Different Rome Definitions
There were 957 subjects (16.1%) with FI who re-
ported at least 1 episode of FI in the last 3 months
(Table 1). Rome III requires at least 1 episode of FI per
month for 3 months, and 412 subjects (6.9%) met this
criterion. Rome IV FI requires at least 2 FI episodes per
month for 6 months, and 196 subjects (3.3%) met this
criterion.
Figure 1 shows that age and sex had a significant
impact on FI prevalence, and these 2 variables inter-
acted; over age 40, females had more FI than males, but
at age 40 or younger, males had more FI than females.
The interaction between age group and gender was sig-
nificant (F [2,5920] ¼ 6.131; P ¼ .002). When the
dependent variable was changed to any FI in the last 3
months, the data were similar and the interaction was
significant (F [2,5920] ¼ 3.834; P ¼ .022).Quality of Life
Quality of life declines with each increase in
frequency of FI, but the largest difference is between
“never had FI” and “FI once per month or less” (Figure 2)
(P < .01).
Subjects were also asked how much stool was usually
lost. Subjects who reported that “soiling or staining un-
derwear only” was typical for them had significantly
worse quality of life (45.2 compared with 50.1 for
physical component; 45.0 compared with 49.8 for the
mental component of quality of life with FI). Losing moreda United Kingdom All cases
¼ 350)
–19%
13.3% (n ¼ 266)
CI, 12%–15%b




5.7% (n ¼ 114)
CI, 5%–7%b




2.7% (n ¼ 54)
CI, 2%–3%b
3.3% (n ¼ 196)
CI, 3%–4%
nited Kingdom at P < .05.
Figure 1. Effects of age and sex on the prevalence of FI. FI
was diagnosed by the Rome IV criteria. These data include
approximately equal numbers of subjects from the United
States, Canada, and the United Kingdom. In subjects less
than 40 years of age, females (red bars) had significantly (P <
.05) less FI than males (blue bars), but after age 40, females
had more FI than males (P < .05).solid or liquid stool significantly increased the impact of
FI on quality of life.Independent Risk Factors for Fecal
Incontinence
The significant independent predictors of any FI
(Table 2) were gender (more prevalent in females than
males), age (most prevalent in the oldest group), hard or
lumpy stools, loose or watery stools, urgency to defecate,
abdominal pain, psychological stress affecting bowel
function, and self-ratings of poor health. There were 941
cases with any FI in the sample, and 23.7% of them were
identified by these predictors. The Nagelkerke R-Square
was 0.281.Figure 2. FI prevalence causes decreased physical and
mental components of quality of life on the Short Form-8
scale. Confidence intervals are small, and all pairs of bars
are significantly different at P < .001.There were 412 Rome III FI patients of whom 18.7%
were identified by these predictor variables. Nagelkerke
R-Square was 0.310. The predictor variables were the
same as any FI except for gender.
For Rome IV there were 196 patients with FI of whom
12.8% were identified by the predictor variables. The
Nagelkerke R-Square was 0.305. The predictor variables
were the same as Rome III except for abdominal pain and
self-rating of poor health.
Between-Country Differences in Fecal
Incontinence
The prevalence of any FI was greater in the United
States (17.5% for any FI, 8.3% for Rome III, and 4.2% for
Rome IV) compared with the United Kingdom (13.3%,
5.7%, and 2.7). Canada was intermediate.
Race and ethnicity were not correlated with FI in any
country, but the questions for race and ethnicity differed
among countries. To control for this, prevalence rates
among countries were compared for white subjects only,
and the between-country differences in FI remained
significant. To identify factors that could explain
between-country differences in any FI, logistic regression
was used to identify variables that separated countries
(P < .05), correlated with FI at r  .2, and eliminated
between-country differences in FI prevalence when these
covariates were entered. Only 2 variables met these
criteria: the sensation of urgency before FI, and reports
of frequent diarrhea. A similar outcome was found for
predicting Rome III and Rome IV FI.
Discussion
In this random sample survey of 3 English language
countries, we asked subjects to describe their experience
of FI in terms of frequency, duration, and usual amount
of stool lost. The overall prevalence of FI is 16.1% based
on any report of an episode of FI in the last 3 months.
The Rome III criteria exclude fewer subjects and identify
6.9% as having FI. The Rome IV criteria identify only
3.3% of the population because limiting FI to individuals
with a frequency of twice a month and a duration of 6
months or longer excludes many. The Rome IV criteria
exclude 4 out of every 5 individuals with occasional FI
from an FI diagnosis.
The estimates for Rome III prevalence are consistent
with estimates in other large community samples. Prev-
alence varies from 8%1 to 15%2 depending on the
diagnostic criteria used, the age of the subjects selected,
and comorbid diagnoses. These data have the advantages
of drawing from large random samples of subjects and
well-balanced age groups and sex distribution making it
easier to assess the impact of modifications to the diag-
nostic criteria on prevalence rates.
Data from clinics may give higher estimates of the
prevalence of FI than these community samples. In
Table 2. Logistic Regression to Identify Independent Predictors of FIa
Variable
Any FI Rome III FI Rome IV FI
Wald Significance Wald Significance Wald Significance
Sex 13.601 0.000 1.080 0.299 0.324 0.569
Age 110.565 0.000 64.194 0.000 62.394 0.000
Education 1.120 0.290 0.230 0.632 0.101 0.751
Hard/lumpy stools 7.343 0.007 9.379 0.002 10.547 0.001
Loose/watery stools 76.480 0.000 61.491 0.000 20.486 0.000
Urgency 134.405 0.000 84.805 0.000 46.481 0.000
Abdominal pain 13.168 0.000 20.111 0.000 1.139 0.286
Irritable bowel syndrome 2.780 0.095 3.428 0.064 1.887 0.170
Diabetes mellitus 3.235 0.072 0.380 0.538 0.810 0.368
Anxiety medication weekly 1.450 0.229 0.696 0.404 0.001 0.978
Depression medication weekly 3.305 0.069 1.348 0.246 2.073 0.150
Psychological stress 50.596 0.000 19.182 0.000 18.451 0.000
Self-rating of health 8.929 0.003 7.041 0.008 0.321 0.571
FI, fecal incontinence.
aWald coefficients adjust for all other variables in the model; they are bolded if significant at P < .05.patients with neurologic disorders, such as dementia13
and spinal cord injury,14 FI prevalence is elevated. In
patients with urinary incontinence, inflammatory bowel
disease,15 diabetes mellitus,16 and a history of pelvic
surgery,17 prevalence rates are also higher.Quality of Life Impact of Fecal Incontinence
The restrictive criteria of Rome IV leave many people
who have infrequent FI with no diagnosis or treatment
guideline. To determine whether these more restrictive
criteria for FI diagnosis are helpful, we investigated the
association of symptoms with impairment in quality of
life. As the frequency of FI increases, quality of life de-
clines, but the largest difference is between continence
and having any FI. Similar effects are seen for the effect
of duration of FI symptoms and amount of stool lost (ie,
the presence of any FI has more impact on quality of life
than differences in duration or amount of stool lost).
More than half of people with FI (56.9%) have it less
often than monthly, and 29.8% of the 957 people with
any FI have had FI symptoms for less than 6 months.
These individuals with short-term FI have a quality of life
impact similar to subjects with long-term FI, suggesting
that they might be equally in need of treatment. This
raises questions about the appropriateness of the
restrictive criteria used to diagnose FI in the Rome IV
questionnaire.
In the small group who fulfilled all the criteria for
Rome IV FI, most (70.4%; 138/196 subjects) report that
their FI episodes usually consist of soiling of underwear.
This subgroup would not be included in some clinical
research studies that require loss of measurable amount
of solid or liquid stool.
Do the Rome IV criteria succeed in separating a
group of individuals with more severe FI who may be
in greater need of medical care? Yes, they do thisbecause quality of life is correlated with the severity
of FI. However, the criteria also have negative con-
sequences; the largest effect of FI on quality of life
exists for having any FI, even if it occurs less than
once a month and is of short duration. These subjects
with milder forms of FI may benefit from treatment.
Our results suggest that FI should be diagnosed in
any individual who reports 2 or more episodes of
fecal soiling in the past 3 months (2 episodes are
required to avoid diagnosing FI in an individual with
diarrhea caused by food-borne infection). This more
inclusive diagnosis should be accompanied by infor-
mation on the frequency, duration, and amount of
fecal soiling because these characteristics may guide
clinicians to the best treatment for individual
patients.Risk Factors for Fecal Incontinence
The multivariate regression analyses to assess risk
factors were robust because nearly 6000 participants
were surveyed. FI was more prevalent in older sub-
jects, those with urge sensations preceding defecation,
loose or watery stools, hard or lumpy stools, abdominal
pain, physician diagnoses of irritable bowel syndrome
or diabetes mellitus, and those reporting greater effects
of psychological stress on bowel function. Female
subjects have a higher prevalence of FI than males,
which agrees with many previous reports.18 Unlike
some previous studies,1 no association of FI diagnosis
with the use of antianxiety medications or years of
education was found.
Abdominal pain was a risk factor for FI independent
of irritable bowel syndrome diagnosis. The role of
abdominal pain in FI is unknown, but it may identify
patients with comorbid neurologic or other illnesses that
predispose to FI.3
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Countries
The prevalence of Rome IV–defined FI was signifi-
cantly greater in the United States than in the United
Kingdom, with the rate in Canada being intermediate. In
contrast, the rate of any FI was significantly higher in
both the United States and Canada compared with the
United Kingdom. These differences were unrelated to
race and ethnicity because an analysis limited to white
subjects showed the same differences among the United
States, Canada, and the United Kingdom. When tested for
possible variables that could explain between-country
differences, the only variables found were urge sensa-
tions before defecation and loose or watery stools. These
variables eliminated between-country differences in
prevalence when entered individually or together, and
differences in these rates among countries may therefore
account for the national prevalence differences observed.
Study Limitations
This study has limitations. First, subjects with de-
mentia were not included in the survey because that
subpopulation is not accessible via the Internet. Because
both dementia and FI increase as people grow older, we
may have underestimated the prevalence of FI. Second,
anal incontinence was not assessed because there was no
question on flatus. This will be addressed in an upcoming
study. Third, several potential risk factors, such as body
weight,3 urinary incontinence, mobility impairment,3 and
pelvic floor muscle injuries,5 were not measured and
may be associated with FI. Fourth, all questions were
retrospective, and it is unknown whether subjects who
answered that their FI episodes were “usually” soiling,
ever had solid or liquid stool losses that could influence
the success of a treatment for FI. Future studies should
include a prospective assessment to estimate variability
in symptoms. Finally, FI is embarrassing to discuss with
others and this may lead to underestimates even when
the survey is anonymous.
Recommendations to Clinicians
This study draws attention to the variability in the
presentation of FI by showing that more than half of
individuals with FI have it less than monthly and two-
thirds have it for less than 6 months. Severity of FI is
associated with greater quality of life impact. Some of
these individuals may benefit from conservative treat-
ments, but everyone with FI has a significant quality of
life impact and may require medical diagnosis and
management guidelines.
This study supports the following recommendations:
(1) Redefine FI by identifying all individuals with FI 2 or
more times in 3 months whether or not they meet a
frequency or duration criteria. Always report additionalinformation on the frequency, duration, and amount of
stool lost to help clinicians select the best treatment. (2)
Develop algorithms for treating FI based on the apparent
severity of the disorder. Conservative measures are
easily taught and may be helpful to many individuals if
appropriately targeted.19 (3) Screen for FI in all patients
with diarrhea and urgency because those individuals are
more likely to have FI. (4) In clinical care, identify the
causes of diarrhea and urge sensation to see if they are
modifiable. (5) Identify FI patients who have abdominal
pain to understand the reasons for this association and
the implications for treatment.References
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